focus -WSS

focus

author：hotspot 2025-09-28 18:57:25 - browse：3354

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Can Threads overtake X, formerly known as Twitter? Experts weigh in.

WSS

Leukemia patients are helped by Syndax's new type of therapy

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

AI models in health care face new federal disclosure requirements

Congenital heart disease patients face new threat of heart failure

Supreme Court wrestles with OxyContin maker's bankruptcy deal

SCOTUS to consider access to abortion pill mifepristone

leisure time

focus

hotspot

Supreme Court strikes down use of affirmative action

Choosing scientific sides in the fight against Alzheimer's

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Hospitals use virtual reality to design more inclusive rooms for kids

Walensky prepares to leave CDC — and Congress — behind

Teach medical students about patients with intellectual disabilities

Heart attack and stroke risk calculators need revising

CMS should re

At least 13 dead in Texas as scorching temps continue

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

knowledge

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Congenital heart disease patients face new threat of heart failure

Judge rejects Trump's counterclaim against E. Jean Carroll

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

More regulation could be coming for drug ads

Wikipedia

Wikipedia

focus

focus